반응 #68047
ord-473148dd016b4c6ba71b60824cefb0a1
반응 방정식
반응물
시약
반응 조건
후처리
- 1workup.ADDITIONwas added
- 2기타The solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform
- 3workup.ADDITIONwere added
- 4기타The organic layer was separated
- 5추출the aqueous layer was extracted with chloroform
- 6세척washed with aqueous saturated sodium chloride solution
- 7건조dried over anhydrous magnesium sulfate
- 8기타the solvent was removed under reduced pressure
- 9기타The residue thus obtained
- 10기타was purified by silica gel column chromatography [eluent; chloroform:methanol=10:1]
실험 절차
To 2 mL of a chloroform solution containing 0.25 g of methyl 1-(2-(4-((tert-butoxycarbonyl)(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate, 2 mL of trifluoroacetic acid was added and stirred for 16 hours. The solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform were added. The organic layer was separated, and the aqueous layer was extracted with chloroform. The organic layer and extracts were combined, washed with aqueous saturated sodium chloride solution, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue thus obtained was purified by silica gel column chromatography [eluent; chloroform:methanol=10:1] to give 0.12 g of methyl 1-(2-(4-((2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate as a white solid.